BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20079021)

  • 21. [Prolactinoma in a child showing high MIB-1 labeling index: a case report].
    Akamine S; Miyamoto T; Sugiura Y; Takehara S; Hiramatsu H; Nishizawa S; Yokota N
    No Shinkei Geka; 2000 Jun; 28(6):547-53. PubMed ID: 10875113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple pituitary adenomas in Cushing's disease.
    Ratliff JK; Oldfield EH
    J Neurosurg; 2000 Nov; 93(5):753-61. PubMed ID: 11059654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphorylation of kinase insert domain receptor by cyclin-dependent kinase 5 at serine 229 is associated with invasive behavior and poor prognosis in prolactin pituitary adenomas.
    Xie W; Liu C; Wu D; Li Z; Li C; Zhang Y
    Oncotarget; 2016 Aug; 7(32):50883-50894. PubMed ID: 27438154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transsphenoidal pituitary resection for preoperative diagnosis of prolactin-secreting pituitary adenoma in women: long term follow-up.
    Feigenbaum SL; Downey DE; Wilson CB; Jaffe RB
    J Clin Endocrinol Metab; 1996 May; 81(5):1711-9. PubMed ID: 8626821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic study of 123 cases of prolactin-secreting pituitary adenomas with special reference to multihormone production and clonality of the adenomas.
    Ma W; Ikeda H; Yoshimoto T
    Cancer; 2002 Jul; 95(2):258-66. PubMed ID: 12124824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocrinological outcome following first time transsphenoidal surgery for GH-, ACTH-, and PRL-secreting pituitary adenomas.
    Kristof RA; Schramm J; Redel L; Neuloh G; Wichers M; Klingmüller D
    Acta Neurochir (Wien); 2002 Jun; 144(6):555-61; discussion 561. PubMed ID: 12111488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of p53, Ki-67 and c-erb B2 in growth hormone-and/or prolactin-secreting pituitary adenomas.
    Botelho CH; Magalhães AV; Mello PA; Schmitt FC; Casulari LA
    Arq Neuropsiquiatr; 2006 Mar; 64(1):60-6. PubMed ID: 16622555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prolactin producing hypophyseal carcinoma. Case report of an extremely rare metastatic tumor].
    Saeger W; Bosse U; Pfingst E; Schierke G; Kulinna H; Atkins D; Gullotta F
    Pathologe; 1995 Sep; 16(5):354-8. PubMed ID: 7479609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Morphological changes in prolactinoma induced by bromocriptine treatment].
    Scanarini M
    Minerva Endocrinol; 1990; 15(1):13-5. PubMed ID: 2274009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple pituitary hormonal abnormalities in a 60-year-old man.
    Am J Med; 1987 Dec; 83(6):1111-9. PubMed ID: 2845777
    [No Abstract]   [Full Text] [Related]  

  • 31. Microsurgical management of prolactinomas - clinical and hormonal outcomes.
    Vivekanandan S; Nayak D
    Neurol India; 2011; 59(6):944-5. PubMed ID: 22234233
    [No Abstract]   [Full Text] [Related]  

  • 32. Histologic and immunohistochemical characterization of spontaneous pituitary adenomas in fourteen cynomolgus macaques (Macaca fascicularis).
    Remick AK; Wood CE; Cann JA; Gee MK; Feiste EA; Kock ND; Cline JM
    Vet Pathol; 2006 Jul; 43(4):484-93. PubMed ID: 16846990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of hypophyseal prolactin-secreting macroadenomas].
    Candrina R; Tosoni M
    Recenti Prog Med; 1989 Sep; 80(9):471-3. PubMed ID: 2595078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Long-term results of surgical therapy of prolactin-secreting hypophysis macroadenomas].
    Candrino R; Tosoni M
    Medicina (Firenze); 1988; 8(4):434-6. PubMed ID: 3244302
    [No Abstract]   [Full Text] [Related]  

  • 35. Neuronal differentiation and expression of neural epitopes in pituitary adenomas.
    Johnson MD; Fan X; Bourne P; Walters D
    J Histochem Cytochem; 2007 Dec; 55(12):1265-71. PubMed ID: 17875653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intensity of prolactinoma on T2-weighted magnetic resonance imaging: towards another gender difference.
    Kreutz J; Vroonen L; Cattin F; Petrossians P; Thiry A; Rostomyan L; Tshibanda L; Beckers A; Bonneville JF
    Neuroradiology; 2015 Jul; 57(7):679-84. PubMed ID: 25845810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ALK7 expression in prolactinoma is associated with reduced prolactin and increased proliferation.
    Principe M; Chanal M; Karam V; Wierinckx A; Mikaélian I; Gadet R; Auger C; Raverot V; Jouanneau E; Vasiljevic A; Hennino A; Raverot G; Bertolino P
    Endocr Relat Cancer; 2018 Sep; 25(9):795-806. PubMed ID: 30012586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Reaction of human pituitary prolactinoma cells to TRH and dopamine in vitro].
    Tong J
    Zhonghua Yi Xue Za Zhi; 1990 Nov; 70(11):649-51. PubMed ID: 1963362
    [No Abstract]   [Full Text] [Related]  

  • 39. Radiosurgery: a useful first-line treatment of prolactinomas?
    Regis J; Castinetti F
    World Neurosurg; 2010 Jul; 74(1):103-4. PubMed ID: 21299992
    [No Abstract]   [Full Text] [Related]  

  • 40. Spherical amyloid deposition in a prolactin-producing pituitary adenoma.
    Gul S; Bahadir B; Dusak A; Kalayci M; Edebali N; Acikgoz B
    Neuropathology; 2009 Feb; 29(1):81-4. PubMed ID: 18498287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.